HDAC6/HSP90-IN-3 is an orally active dual inhibitor of histone deacetylase 6 (HDAC6) and heat shock protein 90 (HSP90), with IC50 values of 28 nM and 0.88 µM, respectively. This compound shows potential for use in research on malignant tumors such as prostate cancer.
Target:
HSP|||HDAC
* VAT and and shipping costs not included. Errors and price changes excepted
